FIRST AMENDMENT TO SUBLEASESublease • November 6th, 2023 • CARGO Therapeutics, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledNovember 6th, 2023 Company IndustryTHIS FIRST AMENDMENT TO SUBLEASE (this “Amendment”) is made as of August 17, 2022 by and between BigHat Biosciences, Inc., a Delaware corporation (“Sublessor”) and Syncopation Life Sciences, Inc., a Delaware corporation (“Sublessee”), with reference to the following facts and objectives:
FIRST AMENDMENT TO SUBLEASESublease • October 20th, 2023 • CARGO Therapeutics, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledOctober 20th, 2023 Company IndustryTHIS FIRST AMENDMENT TO SUBLEASE (this “Amendment”) is made as of August 17, 2022 by and between BigHat Biosciences, Inc., a Delaware corporation (“Sublessor”) and Syncopation Life Sciences, Inc., a Delaware corporation (“Sublessee”), with reference to the following facts and objectives: